In gastric cancer, PD-L1 blockade augments the expression of FABP4/5 and lipid uptake of tissue-resident memory T cells (Trm), thereby extending their lifespan and enhancing their anti-tumor effects [168]. Here, CD274 is linked to neoplasm.